Subject
Pharmacology,Immunology,Immunology and Allergy
Reference67 articles.
1. D. Basak, S. Arrighi, Y. Darwiche, S. Deb, Comparison of anticancer drug toxicities: paradigm shift in adverse effect profile. Life (Basel) 12 (2021).
2. Anticancer drug-induced thyroid dysfunction;Bhattacharya;Eur. Endocrinol.,2020
3. W. Reinhardt, V. Sauter, F. Jockenhövel, G. Kummer, M. Uppenkamp, O. Witzke, et al., Unique alterations of thyroid function parameters after i.v. administration of alkylating drugs (cyclophosphamide and ifosfamide). Exp Clin Endocrinol Diabetes 1999; 107:177-182.
4. The problem of oncostatic specificity of cyclophosphamide (NSC-26271): Studies on reactions that control the alkylating and cytotoxic activity;Hohorst;Can. Treat. Rep.,1976
5. Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450;Marinello;Can. Res.,1984
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献